Immunization of patients with type I dysgammaglobulinemia, in which a deficiency of yG-and yA-and an increase in yM-globulins exists, has usually resulted in production of yM antibodies (1) (2) (3) (4) (5) (6) . In most instances, however, the techniques employed for the measurement of antibody activity have been semiquantitative, and in some cases it has been difficult to distinguish the antibody activities produced by the patient from those contained in the /G given as treatment. Careful study of antibody formation in this syndrome seemed of interest because of the relationship between yM and yG antibody formation (7) (8) (9) (10) and also because of the possibility that a unique opportunity would be provided to obtain evidence in man of whether immunological "memory" might be exhibited with yM antibodies. Studies in animals have suggested that yM antibody formation does not lead to persisting immunological memory (11, 12) .
Antibody formation in a previously reported patient (5) with type I dysgammaglobulinemia was examined further by immunization with bacteriophage OX 174 (OX). Because OX is highly antigenic and the assay for antibody is sensitive and quantitative (13, 14) , this immunization system is advantageous for investigation of the im-* Submitted for publication August 16, 1965 ; accepted May 16, 1966. Supported in part by grants Am 02443, AI 28-03, AI 02349, and AI 01821 from the National Institutes of Health; by the Office of the Surgeon General, Department of the Army; and by the Commission on Immunization of the Armed Forces Epidemiological Board.
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Methods
Patient. The patient, J. T., had a 'yM concentration of 1.8 g per 100 ml and -yG and yA concentrations of less than 2 mg per 100 ml as determined by immunodiffusion analysis. The concentration of -yD in the patient's serum 1 was less than 0.003 mg per ml (normal concentration, 0.02 to 0.05 mg per ml). Although -yG was not identified by immunoelectrophoresis or by micro-Ouchterlony double diffusion of the patient's serum obtained before treatment with Red Cross -y-globulin, its presence was demonstrated by Preer double diffusion (18) ; trace amounts of this immunoglobulin were therefore present. During the current study, the patient was receiving Red Cross y-globulin (-yG) as treatment, 16 ml or 2.64 g every 6 weeks. From day 191 to day 321 (Table I), -yG therapy was discontinued. The 'yG concentration in the patient's serum during this interval declined to less than 7 mg per 100 ml. One lot of -yG used for therapy was tested for anti-OX activity and none was demonstrated.
Measurement of serum immunoglobulins. During the period of study 'yG-and -yM-globulins in the patient's serum were measured by single diffusion (Oudin) as described by Rubinstein (19) with antisera specific for human yG-, 'yA-, and -yM-globulins (20) .
Antigen. The preparation of the bacteriophage OX has been described previously (15) . Immunization. The patient was immunized by intramuscular injection in the deltoid area of 0.1 ml of a phage preparation containing 10" particles per ml. Blood was obtained by venipuncture at intervals after immunization.
Antibody titrations. The assay for antibody was carried out by the methods described by Adams (21 (20) . The results shown in Figure 2 were obtained as indicated above, except that fractions of 0.24 ml were collected with the Isco density gradient fractionator.6 IgM was quantitated by radial diffusion (25) with anti-,yM immuno-plates.7
Gel filtration on G-200 Sephadex was performed with a 0.8-X 113-cm column equilibrated in 1.0 M NaCl, 0.1 M pH 8.0 Tris-HCl. One ml of normal serum or the patient's serum was applied and eluted with the same buffer. One-ml fractions were collected, and their absorption at 277 muit was determined. The fractions were analyzed for immunoglobulins by micro-Ouchterlony double diffusion employing antisera specific for yG, yA, and yM.
Antibody was also treated with 2-mercaptoethanol (2-ME) as previously described (11) . Antibody activity destroyed by 2-ME treatment was presumed to be 19 S, whereas that resistant to such treatment was presumed to be 7 S (26).
Results
The results of immunization of the patient with 50X are shown in Table I t Here the identification of antibody activity as 7 S or 19 S was based on its susceptibility to 2-mercaptoethanol (2-ME). k is the rate constant of phage inactivation.
t Similar k with or without 2-ME. tivity behaved as 19 S. These results confirmed previous studies of the patient's immune response, in which only 19 S antibodies were produced (5). At 114 days, the serum antibody activity had declined to a total k of 0.575, but now antibody behaving in 2-ME as 7 S was detected. At 147 and 177 days, the serum k declined further, and by 177 days virtually all of the small residual antibody activity was of the 7 S type. At this time a third injection of 1010 OX was given and 14 days later antibody activity again assayed. There were marked increases in both the 19 S and 7 S activities. Analysis of the 191-day serum by sucrose density gradient ultracentrifugation revealed the presence of slowly sedimenting and rapidly sedimenting antibody activities. As shown in Table  II the slowly sedimenting antibody activity was resistant to 2-ME treatment, whereas the rapidly sedimenting antibody activity was largely destroyed by 2-ME treatment. By 307 days, the serum k value had declined to 0.64, with 0.5 as 7 S. After a fourth injection of OX on day 307 marked in- Figure 1 . Protein reacting with anti-yM was identified both in the 19 S fractions and also in the 7 S fractions. yG, passively acquired as treatment, was identified only in the 7 S fractions. As shown in Figure 2 , gel filtration of the patient's serum on Sephadex G-200 also revealed protein reacting with anti-yM in the 7 S region. Noteworthy is the virtual absence of a 7 S peak in the patient's serum like that seen in the normal serum shown for contrast.
These studies indicate that the patient's serum contained slowly sedimenting (approximately 7 S) yM protein. This observation could have been caused by inadequate separation of 19 S yM from 7 S proteins because of the increased concentration of 7M in the patient's serum. Density gradient ultracentrifugation of serum from a patient with macroglobulinemia showed, however, that even in the presence of a yM concentration of 3 g per 100 ml, 7 S yG-and 19 S yM-globulins could be adequately separated. Furthermore, when the fractions containing light yM from the patient were recentrifuged, the -yM again sedimented in the 7 S area. Finally, as shown in Figure 3 , repeat examination of the patient's serum by density gradient ultracentrifugation and analysis of the fractions for their concentrations of yM revealed two major EFFLUENT VOLUME (ml) EFFLUENT VOLUME (ml) To determine whether the light yM possessed antibody activity, we examined its ability to neutralize OX. Serum obtained on day 191 containing anti-OX activity in the slowly sedimenting fractions was separated by density gradient ultracentrifugation, and the fractions from the 7 S area were pooled and dialyzed against saline. In these separations the patient's isoagglutinin, anti-B, served as a marker for the 19 S-containing fractions, and the therapeutically administered Red Cross yG-globulin served as a marker for the 7 S fractions. The 7 S pool was divided into 5 fractions and treated as shown in Table III . One fraction was absorbed with anti-yG, a second fraction with anti-yA, and a third fraction with anti-yM.
To the fourth fraction, 13 jug N egg albumin was added, and this was absorbed with anti-egg albumin. This fraction served as a control for nonspecific effects of immunoprecipitation. A fifth sample served as a control to indicate the starting quantity of antibody. All of the antisera employed in these absorptions were shown by prior analysis to be free of anti-0X activity. As indicated in Table III , absorption with anti-yG essentially completely removed the anti-0X activity. Absorption with anti--yM and anti-yA reduced the activity by approximately 50%7. These latter reductions may reflect the presence of specific antibody in the yA and the slowly sedimenting yM, or they may have been due to residual anti-yG activity in the form of yG-anti-yG complexes in the absorbed anti-yM and anti-yA sera. It appears, at any rate, that the 7 S neutralizing antibody was associated principally with the yG class of immunoglobulins; trace quantities of this class had been demonstrated in the patient's serum before any treatment with Red Cross yG-globulin. These separations and analyses were repeated on another occasion, and essentially the same results were obtained.
Discussion
Immunization of patients having type I dysgammaglobulinemia (1-6) with antigens such as typhoid vaccine, tetanus toxoid, and poliomyelitis (Salk) vaccine has, in general, resulted in rather low levels of antibody activity. However, these 
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VVI.,%~ patients have often shown strikingly high titers of 19 S isoagglutinins against A or B erythrocytes, as was true also with our patient (5). Against typhoid, our patient produced low titers of 19 S anti-H and anti-O, and these titers remained low and as 19 S on reimmunization. The insensitivity and the semiquantitative nature of this agglutinin assay, however, prompted the present further investigation with OX.
The antibody response to OX in normal humans and other mammals consists of an initial shortlived formation of rapidly sedimenting (19 S) antibodies and a later longer-lasting formation of slowly sedimenting (7 S) antibodies (11) . Immunological memory has been demonstrated for both 19 S and 7 S antibodies. However, the "memory" associated with 19 S antibody is usually transient; it was no longer demonstrable in guinea pigs when the interval between the first and second stimulation was 1 month, whereas that associated with 7 S was persistent for a minimum of 1 year. Similar results have been obtained in studies with poliovirus (12) . In contrast to these results, Nossal, Ada, and Austin (28) have obtained 19 S immunological memory by challenging rats with minute amounts of flagella antigen followed 6 weeks later with a larger dose. Also, Borel, Fauconnet, and Miescher (29) obtained a 19 S anamnestic response in neonatal rabbits immunized with human red blood cells. The immune response to 0X in the present patient differed from that in normal subjects in several respects. First, the predominance of 7 S antibody usually seen with prolonged immunization did not occur, and most of the antibody found was 19 S even after the fifth injection of antigen. Seven S antibody was produced only late in the course of immunization but then in increasing amounts. Most of the 7 S anti-OX activity was associated with -yG as demonstrated by its removal after absorption with a specific anti-yG serum. Secondly, the duration of synthesis of 19 S antibody appeared to be prolonged, as shown by the half-time of 13 days during the period from day 38 to day 177. The biological half-time of y1-macroglobulin in normal human subjects as determined by Barth The existence of long-lived 19 S immunological memory in this patient may reflect an intrinsic abnormality of her 19 S antibody synthesizing mechanism. Another possibility is that our patient's immunological status was changing during the rather long period of study. That this may occur is shown by the observations of Rosen and his colleagues (1) on a patient (F. E.) with congenital agammaglobulinemia who inexplicably began to produce measurable amounts of yM protein.
Repeated analysis of the immunoglobulins of our patient during the past 3 years (see Table I ) has not shown any remarkable changes; the 7yM concentration has varied slightly, the yG concentration has varied in relation to the injections of exogenous yG, and yA has not been detected. It must be noted, however, that the amount of 7 S antibody formed in response to injection of QX in this patient has steadily increased. This may be the result of repeated immunization but also could indicate a change in the patient's immunological status during the period of study. Finally, a third possibility is that the normal controls of 19 S antibody synthesis are not operative in the patient, and in their absence the full capability of the 19 S system is revealed. It has been shown by Finkelstein and Uhr (8) in guinea pigs that the production of 19 S antibody can be inhibited by passive administration of 7 S antibody. Similar results have been obtained in other immunization systems in rabbits (9) and in humans (10). Hence, it is possible that 7 S antibody persisting from the primary response may inhibit a potential secondary 19 S response. In patients with type I dysgammaglobulinemia the marked deficiency of yG-and yA-globulins may allow yM antibody production to occur largely free of the inhibitory effects of yG antibody. None of these three possibilities can be entirely excluded although on the basis of the available data one might prefer the last explanation.
Although the slowly sedimenting yM in this patient's serum appears to be a naturally occurring component among her y-globulins, its relation to 19 S yM is not clear. Killander (31) Absorption of the slowly sedimenting antibody activity with antisera specific for the various immunoglobulins indicated that most of the antibody activity was associated with yG. However, in view of the reductions after absorption with anti-yM and anti-yA, the presence of some activity associated with these immunoglobulins cannot be excluded. Finally, whether the immunoglobulins of this patient are analogous to the somewhat similar and intriguing immunoglobulins of the elasmobranch, Mustelus canis (smooth dogfish) (35) , cannot be determined at this time.
Summary
Antibody formation in type I dysgammaglobulinemia, a syndrome characterized by deficiency of yA-and yG-and elevation of yM-globulins, was studied by immunization with bacteriophage OX 174. The bulk of the antibody formed was of the 19 S type even after five injections of antigen. However, after the second injection of antigen and thereafter significant amounts of yG antibody were produced.
The 
